Akt kinase LANCL2 functions as a key driver in EGFR-mutant lung adenocarcinoma tumorigenesis

Yuqing Lou(Shanghai Jiao Tong University), Baohui Han(Shanghai Jiao Tong University)

Cell Death and Disease

February 10, 2021

10.1038/s41419-021-03439-8

Cited by 22

Related Papers

PlGF knockdown attenuates hypoxia-induced stimulation of cell proliferation and glycolysis of lung adenocarcinoma through inhibiting Wnt/β-catenin pathway

|Cancer Cell International|2021|22

Mimicking the BIM BH3 domain overcomes resistance to EGFR tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer

|Oncotarget|2017|19

PLGF Knockdown Attenuates Hypoxia-Induced Stimulation of Cell Proliferation and Glycolysis of Lung Adenocarcinoma Through Inhibiting Wnt/β-Catenin Pathway

|Research Square|2020|0